Lv4
430 积分 2025-01-07 加入
Design of the First-in-Human Study of IONIS-MAPTRx, a Tau-lowering Antisense Oligonucleotide, in Patients With Alzheimer Disease (S2.006)
1天前
求助中
Antisense therapy in a rat model of Alexander disease reverses GFAP pathology, white matter deficits, and motor impairment
1个月前
已完结
Chemical Insights into Oligonucleotide–Protein Binding for Therapeutic Applications
3个月前
已完结
Deletion of the Microtubule‐associated protein tau (Mapt−/−) results in diastolic heart failure and altered skeletal muscle function in vivo
3个月前
已关闭
Evidence of a Cardiovascular Function for Microtubule-Associated Protein Tau
3个月前
已完结
Laboratory Diagnosis of Creutzfeldt–Jakob Disease
4个月前
已完结
Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease
5个月前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
6个月前
已完结
Cerebral Small Vessel Disease and Functional Outcome Prediction After Intracerebral Hemorrhage
7个月前
已完结
Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis
7个月前
已完结
皖公网安备34019202002308
